Transcriptional profiling of MCF7 breast cancer cells in response to 5‐Fluorouracil: Relationship with cell cycle changes and apoptosis, and identification of novel targets of p53
- 5 June 2006
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 119 (5), 1164-1175
- https://doi.org/10.1002/ijc.21938
Abstract
The availability of oral precursors of 5‐Fluorouracil (5‐FU) and its favorable results in treating advanced breast cancer have renewed the interest in the molecular mechanisms underlying its cytotoxicity. We have compared the changes in cell cycle and cell death parameters induced by 2 different concentrations of 5‐FU (IC50 and IC80) in the breast adenocarcinoma cell line MCF7. G1/S cell cycle arrest was associated with both concentrations, whereas cell death was mainly induced after IC80 5‐FU. These changes were correlated with gene expression assessed by cDNA microarray analysis. Main findings included an overexpression of p53 target genes involved in cell cycle and apoptosis (CDKN1A/p21, TP53INP, TNFRSF6/FAS and BBC3/PUMA), and significant repression of Myc. High dose 5‐FU also induced a higher regulation of the mitochondrial death genes APAF1, BAK1 and BCL2, and induction of genes of the ID family. Furthermore, we establish a direct causal relationship between p21, ID1 and ID2 overexpression, increased acetylation of histones H3 and H4 and binding of p53 to their promoters as a result of 5‐FU treatment. The relevance of these findings was further studied after interfering p53 expression in MCF7 cells (shp53 cells), showing a lower induction of both, ID1 and ID2 transcripts, after 5‐FU when compared with MCF7 shGFP control cells. This molecular characterization of dose‐ and time‐dependent modifications of gene expression after 5‐FU treatment should provide a resource for future basic studies addressing the molecular mechanisms of chemotherapy in breast cancer.Keywords
This publication has 33 references indexed in Scilit:
- p53-Dependent Transcriptional Repression of c-myc Is Required for G1 Cell Cycle ArrestMolecular and Cellular Biology, 2005
- The impact of MECP2 mutations in the expression patterns of Rett syndrome patientsHuman Genetics, 2004
- Werner syndrome cells escape hydrogen peroxide‐induced cell proliferation arrestThe FASEB Journal, 2004
- Cell-Type-Specific Responses to Chemotherapeutics in Breast CancerCancer Research, 2004
- Werner syndrome protein limits MYC-induced cellular senescenceGenes & Development, 2003
- Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damageNature, 2002
- E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpointsGenes & Development, 2002
- Disruption of p53 in human cancer cells alters the responses to therapeutic agentsJCI Insight, 1999
- Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with ApoptosisJournal of Biological Chemistry, 1998
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994